Exact Mass: 345.147

1-(1-Methoxyethyl)-8,13-dihydroindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-5(7H)-one

16-Methoxycarbonyl naufoline

Pro Glu Thr

Glu Pro Thr

Pro Thr Glu

Thr Pro Glu

Glu Thr Pro

Thr Glu Pro

4,5-DIDEMETHYLSIMMONDSIN

1-BOC-4-[3-(TRIFLUOROMETHYL)PHENYL]-4-HYDROXYPIPERIDINE

2-[4-[1-(1,3-benzodioxol-5-yl)propan-2-yl]piperazin-1-yl]-4-methyl-1,3-thiazole

6-Methylheptanoic acid - cobalt (2:1)

C16H30CoO4 (345.1476)

Metofoline

Isoquinoline,1-[2-(4-chlorophenyl)ethyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-

C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

sodium,methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

C17H24NNaO5 (345.1552)

Piperidine,2-[(4R)-2,2-diphenyl-1,3-dioxolan-4-yl]-, hydrochloride (1:1), (2R)-

Savolitinib

C17H15N9 (345.145)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

Carbamic acid, [5-oxo-5-[4-(trifluoromethyl)phenyl]pentyl]-, 1,1-dimethylethyl ester

1,1,2-trimethyl-3-(4-sulfobutyl)-1h-benz[e]indolium hydroxide, inner salt

C19H23NO3S (345.1399)

3-[1-[5-(Trifluoromethyl)-2-pyridinyl]-4-piperidinyl]-1H-indole

C19H18F3N3 (345.1453)

Piperidine,2-(2,2-diphenyl-1,3-dioxolan-4-yl)-, hydrochloride (1:1)

t-butyl-4-n-z-amino-2-fluoro-benzoate

C19H20FNO4 (345.1376)

3-(3-Trifluoromethyl-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester

1-BOC-4-(4-TRIFLUOROMETHYLPHENOXY)PIPERIDINE

Mal-PEG4-acid

(4-PHENYLPIPERAZIN-1-YL)PIPERIDIN-4-YL-METHANONE DIHYDROCHLORIDE

C16H25Cl2N3O (345.1375)

tert-Butyl 4-(2-(trifluoromethyl)phenoxy)piperidine-1-carboxylate

3-[5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazol-3-yl]-4-methyl-1H-1,2,4-triazole-5-thione

C17H20FN5S (345.1423)

Cobalt bis(2-ethylhexanoate)

C16H30CoO4 (345.1476)

(5,6-Diphenyl-furo[2,3-D]pyrimidin-4-ylamino)-acetic

1-Phenyl-2-propanamine-D-glucaric acid (1:1)

Gevotroline hydrochloride

C19H21ClFN3 (345.1408)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide

2,3,7-Triphenyl-1H-indole

C26H19N (345.1517)

4-(2-(1H-imidazol-4-yl)ethylamino)-2-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile

C17H15N9 (345.145)

(5E)-5-[(1-cyclohexyl-2,5-dimethylpyrrol-3-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione

N-(2-furanylmethyl)-6-(3-methoxyphenyl)-N-methyl-4-quinazolinamine

1-[4-(3-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(4-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

Thr-Pro-Glu

3-Butyl-10-phenylpyrimido[4,5-b]quinoline-2,4-dione

4-[[2-(4-Ethyl-1-piperazinyl)-2-oxoethyl]thio]-1-methyl-2-quinolinone

N-(2-oxolanylmethyl)-2-(1-piperidinyl)-1,3-benzothiazole-6-carboxamide

Methyl 2-[1-(2-methyl-1H-indol-3-yl)-2-naphthyl]hydrazinecarboxylate

Pro-Glu-Thr

Glu-Pro-Thr

Glu-Thr-Pro

Thr-Glu-Pro

Pro-Thr-Glu

2-(3-Pyridyl)-3-(4-toluenesulfonamido)propylazetidine

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-trans)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-cis)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-trans)

1-Methyl-3,4-bis(methoxycarbonyl)-2-trimethylsilyl-5-phenylpyrrole

C18H23NO4Si (345.1396)

N-Methylnuciferine

N-Methylnuciferine, an alkaloid from Lotus Plumule, ameliorate lipopolysaccharide-induced depression-like behavior[1].

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-yl]oxy}oxane-3,4,5-triol

16-methoxycarbonylnaufoline

{"Ingredient_id": "HBIN001926","Ingredient_name": "16-methoxycarbonylnaufoline","Alias": "NA","Ingredient_formula": "C21H19N3O2","Ingredient_Smile": "COC(=O)C1=CN=CC2=C1C=CC3C4=C(CCN3C2)C5=CC=CC=C5N4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13869","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

19-o-methylangustoline

{"Ingredient_id": "HBIN002206","Ingredient_name": "19-o-methylangustoline","Alias": "NA","Ingredient_formula": "C21H19N3O2","Ingredient_Smile": "CC(C1=C2C=C3C4=C(CCN3C(=O)C2=CN=C1)C5=CC=CC=C5N4)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14132","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-2h-pyrrolo[1,2-a]pyrazine-1,4-dione

19-(1-methoxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

19-[(1r)-1-methoxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one